Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Some dibenzo compounds might help treat cancer with fewer side effects.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

The document corrects errors in previous articles, including a reversed term, updated subject weights, hair count data, and reference numbering.

Tangent screens help detect visual field defects from vigabatrin.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Activating TRPV3 reduces skin oil production and increases inflammation, potentially causing dry skin issues.

RTA 408 cream protects mice from radiation skin damage.

Three reliable methods were developed to measure Finasteride and Tamsulosin Hydrochloride in medicines.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Dutasteride effectively treats enlarged prostate with manageable side effects.